Table 1.
Arm A (n = 6) | Arm B (n = 10) | Total (n = 16) (%) | |
---|---|---|---|
Male | 3 | 4 | 7 (44) |
Female | 3 | 6 | 9 (56) |
Stage III | 0 | 2 | 2 (13) |
Stage IV | 6 | 8 | 14 (88) |
ECOG 0 | 5 | 5 | 10 (63) |
ECOG 1 | 1 | 4 | 5 (31) |
Unavailable | 0 | 1 | 1 (6) |
Histology | |||
Cutaneous | 2 | 4 | 6 (38) |
Mucosal | 1 | 0 | 1 (6) |
Acral lentiginous | 0 | 1 | 1 (6) |
Ocular | 0 | 1 | 1 (6) |
Unknown primary | 3 | 4 | 7 (44) |
Prior therapy | |||
Radiation | 3 | 3 | 6 (38) |
Chemotherapy | 2 | 8 | 10 (63) |
Unavailable | 1 | 1 | 2 (13) |